Valuation: Innovassynth Technologies (India) Limited

Market Cap 5.22B 54.71M 46.96M 44.07M 40.25M 75.97M 76.34M 522M 202M 2.63B 205M 201M 8.72B P/E 2024
-73.1x
P/E 2025 -44.1x
Enterprise Value 5.26B 55.16M 47.35M 44.44M 40.59M 76.6M 76.97M 526M 204M 2.65B 207M 203M 8.79B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
21.02%
Yield 2024 *
-
Yield 2025 -
1 day+0.97%
1 week+0.97%
Current month+3.98%
1 month+4.99%
3 months+73.10%
6 months+84.13%
Current year+73.83%
1 week 139.9
Extreme 139.9
139.9
1 month 133
Extreme 133
139.9
Current year 50.1
Extreme 50.1
139.9
1 year 50.1
Extreme 50.1
139.9
3 years 19.5
Extreme 19.5
139.9
5 years 13.55
Extreme 13.55
139.9
10 years 2.43
Extreme 2.43
139.9
Manager TitleAgeSince
Chief Executive Officer 51 2022-02-11
Director of Finance/CFO 52 2025-12-22
Chief Operating Officer - 2025-12-22
Director TitleAgeSince
Chairman 51 2022-02-11
Director/Board Member - 2022-09-01
Director/Board Member 58 2024-04-15
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%+0.97%+40.04%+472.19% 136M
+0.37%+1.74%+4.08%+61.02% 81.17B
+1.57%+5.64%-0.94%+18.39% 38.18B
+1.44%+4.29%+2.79%-19.44% 38.04B
+0.70%+5.93%-7.18%+16.48% 24.39B
-1.17%+3.85%+71.40%+23.16% 22.63B
-0.45%-0.96%+23.95%+18.25% 22.56B
+1.43%-1.22%-40.50%-38.38% 18.37B
+1.00%+0.17%+64.98%-29.11% 15.72B
+0.85%+5.92%+12.90%-0.60% 14.68B
Average +0.67%+2.37%+17.15%+52.20% 27.59B
Weighted average by Cap. +0.65%+2.53%+10.35%+18.65%

Financials

2024 2025
Net sales - -
Net income -8.44M -88.5K -75.96K -71.3K -65.12K -123K -123K -844K -327K -4.26M -332K -325K -14.1M -46.87M -491K -422K -396K -362K -682K -686K -4.69M -1.82M -23.65M -1.85M -1.81M -78.32M
Net Debt 35.78M 375K 322K 302K 276K 521K 523K 3.58M 1.39M 18.05M 1.41M 1.38M 59.79M 43.45M 456K 391K 367K 335K 633K 636K 4.34M 1.68M 21.92M 1.71M 1.67M 72.6M
Logo Innovassynth Technologies (India) Limited
Innovassynth Technologies (India) Limited, formerly Innovassynth Investments Limited, is an India-based company, which is engaged in developing, scaling up and manufacturing of specialty chemicals and pharmaceuticals intermediates. The Company is engaged in custom development and manufacturing. It partners with pharma and diagnostics, organometallics, petrochemical and polymers, flavors and fragrance, and specialty chemical companies worldwide. Through its two business verticals, the Company offers solutions and a range organic chemical portfolio: life sciences - nucleosides and specialty chemicals. Its Life Sciences - Nucleosides vertical includes Nucleosides - Phosphoramidite, Delivery Platforms (GalNAc), Pharma Intermediates, Nucleosides - Reagents & Bio-buffers, and ADC Linkers. Its specialty chemicals include organometallics including pre-catalysts for metallocene, ZN catalysts and donors, polymers additives, ALD/CVD precursors, donors & ligands, and semiconductor chemicals.
Employees
2
Date Price Change Volume
26-08-24 ₹139.90 +0.97% 14,201
  1. Stock Market
  2. Stocks
  3. 533315 Stock